The antiretroviral therapy coverage among male adults living with HIV in Mexico has shown substantial growth over the past decade. As of 2023, the coverage stands at 77 units, marking a significant increase compared to 44 units in 2013. The actual data up to 2023 demonstrate a consistent year-on-year growth with notable increments particularly post-2013. Forecasts for 2024 onwards indicate a continuation of this positive trend, expecting to reach 88 units by 2028.

Highlights of year-on-year variation in the last two years show an uptick of approximately 3.8% and 2.6% respectively. The Compound Annual Growth Rate (CAGR) over the last five years stands at 2.18%, reflecting steady growth in the coverage.

Future Trends to Watch For:

Improved access to healthcare and antiretroviral therapy will likely enhance coverage rates.
Government policies and international aid focused on HIV treatment can significantly impact future projections.
Technological advancements in medication and streamlined distribution channels may expedite growth rates.